EHMT2 and hepatocellular carcinoma: Another interesting study assessed the therapeutic efficacy of a dual G9a histone‐methyltransferase and DNMT1 inhibitor in HCC, showing a synthetic lethal effect of independent G9a and DNMT1 pharmacological targeting [62].